The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Title |
Perphenazine for schizophrenia
|
---|---|
Published in |
Cochrane database of systematic reviews, March 2015
|
DOI | 10.1002/14651858.cd003443.pub3 |
Pubmed ID | |
Authors |
Benno Hartung, Stephanie Sampson, Stefan Leucht |
Abstract |
Perphenazine is an old phenothiazine antipsychotic with a potency similar to haloperidol. It has been used for many years and is popular in the northern European countries and Japan. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 17% |
Unknown | 5 | 83% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 83% |
Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 261 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | <1% |
South Africa | 1 | <1% |
Unknown | 259 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 42 | 16% |
Student > Bachelor | 27 | 10% |
Researcher | 26 | 10% |
Student > Ph. D. Student | 23 | 9% |
Student > Doctoral Student | 13 | 5% |
Other | 41 | 16% |
Unknown | 89 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 58 | 22% |
Nursing and Health Professions | 30 | 11% |
Psychology | 23 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 15 | 6% |
Unspecified | 7 | 3% |
Other | 34 | 13% |
Unknown | 94 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 May 2024.
All research outputs
#6,551,971
of 25,942,066 outputs
Outputs from Cochrane database of systematic reviews
#8,084
of 13,166 outputs
Outputs of similar age
#68,330
of 274,835 outputs
Outputs of similar age from Cochrane database of systematic reviews
#163
of 284 outputs
Altmetric has tracked 25,942,066 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 13,166 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.3. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 274,835 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 284 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.